Galmed Pharmaceuticals

4 Decision Makers · 4 Verified Contacts

📍 Tel Aviv, Tel Aviv, IsraelHealthcare & Medical🗓 Est. 2000👥 Under 10 employees

About Galmed Pharmaceuticals

Galmed develop innovative, proprietary drugs for the treatment of lipids and liver diseases.

Leadership & Decision Makers

Contact details of 4 Galmed Pharmaceuticals decision makers

Ray Morris

CFO

Tuvia Gilat

Co-Founder

Dr. Maya Halperin

CMO

Allen Baharaff

CEO

General Emails

General company emails, e.g. customer support lines

    info@galmedpharma.com

    General Inquiries

    officerinvestor.relations@galmedpharma.com

    Investor Relations

    josh@galmedpharma.com

    Unclassified inbox

Similar Companies like Galmed Pharmaceuticals

1mg

1mg.com
E-commerce & Retail · Gurgaon, Haryana, India · Est. 2015 · 51–100 employees

HQ: Gurgaon, Haryana, India

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Rakuten Medical

rakuten-med.com
Pharmaceuticals · San Diego, CA · Est. 2010 · 101–250 employees

HQ: San Diego, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Explore similar firms in the Healthcare & Medical sector

Company Info

Last updated: 31/07/2025

+972 3-693-8448

Tel Aviv, Tel Aviv, Israel

Legal Name: Galmed Pharmaceuticals Ltd.
Business Type: Public
Employees: 1-10
Rounds: Post-IPO Equity
Founded Date: 2000
Company Type: For Profit
Stock Symbol: NASDAQ:GLMD
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +972 3-693-8448
Last Investment Activity: Sep 22, 2023
Investments Activity: Sep 22, 2023 Jul 14, 2023 Jul 14, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.